Skip to content

The relationship between inspiratory muscle strength and major adverse cardiovascular events and prognosis in patients with coronary heart disease: A retrospective study

The relationship between inspiratory muscle strength and major adverse cardiovascular events and prognosis in patients with coronary heart disease: A retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128064
Enrollment
Unknown
Registered
2026-07-13
Start date
2026-07-13
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The diagnosis of coronary heart disease was confirmed through imaging examinations such as coronary angiography or coronary CT angiography.

Interventions

Normal inspiratory muscle strength group:None
Inspiratory muscle weakness group:None

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Diagnosed with coronary heart disease through imaging examinations such as coronary angiography or coronary CT angiography; 3. Had undergone MIP examination during hospitalization;

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction without reperfusion treatment; 2. Complicated with severe arrhythmia; 3. Acute heart failure, chronic heart failure in the acute stage; 4. Complicated with severe heart valve disease; 5. Accompanied by other serious systemic diseases (such as malignant tumors, severe liver and kidney diseases, and chronic lung diseases, etc.); 6. Dementia, sequelae of stroke, limb deformity or functional disorder; 7. Undergoing assisted ventilation treatment; 8. Using glucocorticoids and neuromuscular blocking agents for treatment; 9. The patient refused or was lost to follow-up.

Design outcomes

Primary

MeasureTime frame
The main adverse cardiovascular events include cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, recurrent angina pectoris, new-onset heart failure or hospitalization due to hea;

Countries

China

Contacts

Public ContactLv Meifen

The Third Affiliated Hospital of Guangzhou Medical University

1759951375@qq.com+86 20 81298030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026